The DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.
Mesenchymal stem cell therapy ameliorates diabetic nephropathy via the paracrine effect of renal trophic factors including exosomes
Open accessAbstract
Bone marrow-derived mesenchymal stem cells (MSCs) have contributed to the improvement of diabetic nephropathy (DN); however, the actual mediator of this effect and its role has not been characterized thoroughly. We investigated the effects of MSC therapy on DN, focusing on the paracrine effect of renal trophic factors, including exosomes secreted by MSCs. MSCs and MSC-conditioned medium (MSC-CM) as renal trophic factors were administered in parallel to high-fat diet (HFD)-induced type 2 diabetic mice and streptozotocin (STZ)-induced insulin-deficient diabetic mice. Both therapies showed approximately equivalent curative effects, as each inhibited the exacerbation of albuminuria. They also suppressed the excessive infiltration of BMDCs into the kidney by regulating the expression of the adhesion molecule ICAM-1. Proinflammatory cytokine expression (e.g., TNF-α) and fibrosis in tubular interstitium were inhibited. TGF-β1 expression was down-regulated and tight junction protein expression (e.g., ZO-1) was maintained, which sequentially suppressed the epithelial-to-mesenchymal transition of tubular epithelial cells (TECs). Exosomes purified from MSC-CM exerted an anti-apoptotic effect and protected tight junction structure in TECs. The increase of glomerular mesangium substrate was inhibited in HFD-diabetic mice. MSC therapy is a promising tool to prevent DN via the paracrine effect of renal trophic factors including exosomes due to its multifactorial action.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Valadi, H., Ekström, K., Bossios, A., Sjöstrand, M., Lee, J. J., & Lötvall, J. O. (2007) · Nature Cell Biology · doi:10.1038/ncb1596 · Cited by 12,834
Friedenstein, A. J., Chailakhyan, R. K., Latsinik, N. V., Panasyuk, A. F., & Keiliss-Borok, I. V. (1974) · Transplantation · doi:10.1097/00007890-197404000-00001 · Cited by 1,431
Mesenchymal Stem Cell-Derived Microvesicles Protect Against Acute Tubular Injury
Bruno, S., Grange, C., Deregibus, M. C., Calogero, R. A., Saviozzi, S., Collino, F., Morando, L., Busca, A., Falda, M., Bussolati, B., et al. (2009) · Journal of the American Society of Nephrology · doi:10.1681/asn.2008070798 · Cited by 1,330
Oxidative Stress as a Major Culprit in Kidney Disease in Diabetes
Forbes, J. M., Coughlan, M. T., & Cooper, M. E. (2008) · Diabetes · doi:10.2337/db08-0057 · Cited by 1,203
Fibroblasts in Kidney Fibrosis Emerge via Endothelial-to-Mesenchymal Transition
Zeisberg, E. M., Potenta, S. E., Sugimoto, H., Zeisberg, M., & Kalluri, R. (2008) · Journal of the American Society of Nephrology · doi:10.1681/asn.2008050513 · Cited by 876
Exosomes Derived from Mesenchymal Stem Cells
Yu, B., Zhang, X., & Li, X. (2014) · International Journal of Molecular Sciences · doi:10.3390/ijms15034142 · Cited by 783
A Glimpse of Various Pathogenetic Mechanisms of Diabetic Nephropathy
Kanwar, Y. S., Sun, L., Xie, P., Liu, F.-Y., & Chen, S. (2011) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev.pathol.4.110807.092150 · Cited by 775
Zhou, Y., Xu, H., Xu, W., Wang, B., Wu, H., Tao, Y., Zhang, B., Wang, M., Mao, F., Yan, Y., et al. (2013) · Stem Cell Research & Therapy · doi:10.1186/scrt194 · Cited by 644
Relationship between Oxidative Stress and Inflammatory Cytokines in Diabetic Nephropathy
Elmarakby, A. A., & Sullivan, J. C. (2012) · Cardiovascular Therapeutics · doi:10.1111/j.1755-5922.2010.00218.x · Cited by 641
Tögel, F., Weiss, K., Yang, Y., Hu, Z., Zhang, P., & Westenfelder, C. (2007) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00339.2006 · Cited by 641
The pathogenesis of diabetic nephropathy
Dronavalli, S., Duka, I., & Bakris, G. L. (2008) · Nature Clinical Practice Endocrinology & Metabolism · doi:10.1038/ncpendmet0894 · Cited by 625
Stromal Cells Protect against Acute Tubular Injury via an Endocrine Effect
Bi, B., Schmitt, R., Israilova, M., Nishio, H., & Cantley, L. G. (2007) · Journal of the American Society of Nephrology · doi:10.1681/asn.2007020140 · Cited by 515
Mediators of Diabetic Renal Disease: The Case for TGF-β as the Major Mediator
Ziyadeh, F. N. (2004) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000093460.24823.5b · Cited by 463
The therapeutic potential of mesenchymal stem cell‐derived extracellular vesicles
Katsuda, T., Kosaka, N., Takeshita, F., & Ochiya, T. (2013) · PROTEOMICS · doi:10.1002/pmic.201200373 · Cited by 423
Advanced Glycation end Products, Oxidative Stress and Diabetic Nephropathy
Yamagishi, S.-I., & Matsui, T. (2010) · Oxidative Medicine and Cellular Longevity · doi:10.4161/oxim.3.2.11148 · Cited by 397
Tomasoni, S., Longaretti, L., Rota, C., Morigi, M., Conti, S., Gotti, E., Capelli, C., Introna, M., Remuzzi, G., & Benigni, A. (2013) · Stem Cells and Development · doi:10.1089/scd.2012.0266 · Cited by 340
Yuyama, K., Sun, H., Sakai, S., Mitsutake, S., Okada, M., Tahara, H., Furukawa, J.-I., Fujitani, N., Shinohara, Y., & Igarashi, Y. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.577213 · Cited by 333
Li, J., Qu, X., & Bertram, J. F. (2009) · The American Journal of Pathology · doi:10.2353/ajpath.2009.090096 · Cited by 316
Yamagishi, S.-I. (2011) · Experimental Gerontology · doi:10.1016/j.exger.2010.11.007 · Cited by 302
Recent advances in understanding the biochemical and molecular mechanism of diabetic retinopathy
Wan, T.-T., Li, X.-F., Sun, Y.-M., Li, Y.-B., & Su, Y. (2015) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2015.08.002 · Cited by 291
Javazon, E. H., Colter, D. C., Schwarz, E. J., & Prockop, D. J. (2001) · STEM CELLS · doi:10.1634/stemcells.19-3-219 · Cited by 260
Masszi, A., Di Ciano, C., Sirokmány, G., Arthur, W. T., Rotstein, O. D., Wang, J., McCulloch, C. A. G., Rosivall, L., Mucsi, I., & Kapus, A. (2003) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00183.2002 · Cited by 242
Activin-like kinase 3 is important for kidney regeneration and reversal of fibrosis
Sugimoto, H., LeBleu, V. S., Bosukonda, D., Keck, P., Taduri, G., Bechtel, W., Okada, H., Carlson, W., Bey, P., Rusckowski, M., et al. (2012) · Nature Medicine · doi:10.1038/nm.2629 · Cited by 231
Recent advances in understanding the biochemical and molecular mechanism of diabetic nephropathy
Sun, Y.-M., Su, Y., Li, J., & Wang, L.-F. (2013) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2013.02.120 · Cited by 226
The role of TGF-β and epithelial-to mesenchymal transition in diabetic nephropathy
Hills, C. E., & Squires, P. E. (2011) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2011.06.002 · Cited by 225
van Koppen, A., Joles, J. A., van Balkom, B. W. M., Lim, S. K., de Kleijn, D., Giles, R. H., & Verhaar, M. C. (2012) · PLoS ONE · doi:10.1371/journal.pone.0038746 · Cited by 204
Phenotypic transitions and fibrosis in diabetic nephropathy
Simonson, M. S. (2007) · Kidney International · doi:10.1038/sj.ki.5002180 · Cited by 202
Myofibroblasts and the progression of diabetic nephropathy
Essawy, M., Soylemezoglu, O., Muchaneta-Kubara, E., Shortland, J., Brown, C., & El Nahas, A. (1997) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/12.1.43 · Cited by 199
Role of TGF-β signaling in extracellular matrix production under high glucose conditions
Li, J., Huang, X. R., Zhu, H., Johnson, R. J., & Lan, H. Y. (2003) · Kidney International · doi:10.1046/j.1523-1755.2003.00016.x · Cited by 160
Kuroda, Y., Kitada, M., Wakao, S., & Dezawa, M. (2011) · Archivum Immunologiae et Therapiae Experimentalis · doi:10.1007/s00005-011-0139-9 · Cited by 113
Mesenchymal stem cells and kidney repair
Morigi, M., & Benigni, A. (2012) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfs556 · Cited by 109
Mesenchymal stem cells in kidney inflammation and repair
Wise, A. F., & Ricardo, S. D. (2011) · Nephrology · doi:10.1111/j.1440-1797.2011.01501.x · Cited by 102
Ezquer, F. E., Ezquer, M., Simon, V., Pardo, F., Yáñez, A. J., Carpio, D., & Conget, P. A. (2009) · Transplantation and Cellular Therapy · doi:10.1016/j.bbmt.2009.07.022 · Cited by 99
Li, D., Wang, N., Zhang, L., Hanyu, Z., Xueyuan, B., Fu, B., Shaoyuan, C., Zhang, W., Xuefeng, S., Li, R., et al. (2013) · Stem Cell Research & Therapy · doi:10.1186/scrt314 · Cited by 84
Tang, S. C. W., Leung, J. C. K., Chan, L. Y. Y., Tsang, A. W. L., & Lai, K. N. (2006) · Journal of the American Society of Nephrology · doi:10.1681/asn.2005101113 · Cited by 79
Aziz, M. T. A., Wassef, M. A. A., Ahmed, H. H., Rashed, L. A., Mahfouz, S., Aly, M. I., Hussein, R. E., & Abdelaziz, M. (2014) · Diabetology & Metabolic Syndrome · doi:10.1186/1758-5996-6-34 · Cited by 79
Conditioned mesenchymal stem cells produce pleiotropic gut trophic factors
Watanabe, S., Arimura, Y., Nagaishi, K., Isshiki, H., Onodera, K., Nasuno, M., Yamashita, K., Idogawa, M., Naishiro, Y., Murata, M., et al. (2013) · Journal of Gastroenterology · doi:10.1007/s00535-013-0901-3 · Cited by 78
Self-citationEzquer, F. E., Giraud‐Billoud, M., Carpio, D., Cabezas, F., Conget, P. A., & Ezquer, M. (2015) · BioMed Research International · doi:10.1155/2015/164703 · Cited by 65
Zhang, Y., Ye, C., Wang, G., Gao, Y., Tan, K., Zhuo, Z., Liu, Z., Xia, H., Yang, D., & Li, P. (2013) · BioMed Research International · doi:10.1155/2013/526367 · Cited by 64
Nagaishi, K., Ataka, K., Echizen, E., Arimura, Y., & Fujimiya, M. (2013) · Hepatology · doi:10.1002/hep.26975 · Cited by 57
Self-citationRenal and Bone Marrow Cells Fuse after Renal Ischemic Injury
Li, L., Truong, P. V., Igarashi, P., & Lin, F. (2007) · Journal of the American Society of Nephrology · doi:10.1681/asn.2007030284 · Cited by 55
Zhang, K., Zhang, H., Xiang, H., Liu, J., Liu, Y., Zhang, X., Wang, J., & Tang, Y. (2013) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2013.1396 · Cited by 49
Wu, H., Shi, Y., Deng, X., Su, Y., Du, C., Wei, J., Ren, Y., Wu, M. T., Hou, Y., & Duan, H. (2015) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2015.09.008 · Cited by 36
Under the right conditions: protecting podocytes from diabetes-induced damage
Ali, I. H., & Brazil, D. P. (2013) · Stem Cell Research & Therapy · doi:10.1186/scrt330 · Cited by 7
Cited by
Immunoregulatory mechanisms of mesenchymal stem and stromal cells in inflammatory diseases
Shi, Y., Wang, Y., Li, Q., Liu, K., Hou, J., Shao, C., & Wang, Y. (2018) · Nature Reviews Nephrology · doi:10.1038/s41581-018-0023-5 · Cited by 1,223
Toh, W. S., Lai, R. C., Hui, J. H. P., & Lim, S. K. (2017) · Seminars in Cell & Developmental Biology · doi:10.1016/j.semcdb.2016.11.008 · Cited by 502
Li, L., Zhang, Y., Mu, J., Chen, J., Zhang, C., Cao, H., & Gao, J. (2020) · Nano Letters · doi:10.1021/acs.nanolett.0c00929 · Cited by 404
Börger, V., Bremer, M., Ferrer-Tur, R., Gockeln, L., Stambouli, O., Becic, A., & Giebel, B. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18071450 · Cited by 371
Targeting inflammation to treat diabetic kidney disease: the road to 2030
Rayego-Mateos, S., Rodrigues-Diez, R. R., Fernandez-Fernandez, B., Mora-Fernández, C., Marchant, V., Donate-Correa, J., Navarro-González, J. F., Ortiz, A., & Ruiz-Ortega, M. (2023) · Kidney International · doi:10.1016/j.kint.2022.10.030 · Cited by 366
Metadata
- Authors
- Nagaishi, K., Mizue, Y., Chikenji, T., Otani, M., Nakano, M., Konari, N., & Fujimiya, M.
- Venue
- Scientific Reports
- Published
- 2016-10-10
- Volume
- 6
- Issue
- 1
- Pages
- 34842-34842
- ISSN
- 2045-2322 (ISSN-L)
- OpenAlex
- W2530090297
- Cited by
- 257
- References
- 44
- FWCI
- 10.49
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.